The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
| Autor: | Trullas, A., Delgado, J., Genazzani, A., Mueller-Berghaus, J., Migali, C., Müller-Egert, S., Zander, H., Enzmann, H., Pignatti, F. |
|---|---|
| Zdroj: | In ESMO Open June 2021 6(3) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|